|
Volumn 22, Issue 1 A, 2002, Pages 311-318
|
Tumor M2-pyruvate kinase in lung cancer patients: Immunohistochemical detection and disease monitoring
a a a a a a |
Author keywords
Lung cancer; Therapy monitoring; Tumor M2 pyruvate kinase
|
Indexed keywords
CISPLATIN;
EDETIC ACID;
ETOPOSIDE;
GEMCITABINE;
NAVELBINE;
PYRUVATE KINASE;
PYRUVATE KINASE M2;
TUMOR MARKER;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CASE REPORT;
CAUSE OF DEATH;
DIAGNOSTIC VALUE;
HISTOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
LUNG CANCER;
MALE;
PATIENT MONITORING;
PRIORITY JOURNAL;
TISSUE SECTION;
TUMOR CLASSIFICATION;
TUMOR REGRESSION;
TUMOR VOLUME;
AGED;
CARCINOMA, NON-SMALL-CELL LUNG;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
MONITORING, PHYSIOLOGIC;
PYRUVATE KINASE;
REAGENT KITS, DIAGNOSTIC;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0036249158
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (82)
|
References (23)
|